Castle Biosciences, Inc.
Castle Biosciences, Inc. (CSTL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CSTL · as of Jun 8, 2026
Key Statistics
Explore Castle Biosciences, Inc. Data
cstl stock data · financialsAbout Castle Biosciences, Inc.
Castle Biosciences, Inc. a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a m…
what is castle biosciences, inc. · cstl stock overview · castle biosciences, inc. company profile · who is castle biosciences, inc. ceo · cstl NASDAQ · castle biosciences, inc. headquarters · castle biosciences, inc. business segments
About Stock Overview & Key Data
Castle Biosciences, Inc. (CSTL) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 25, 2019. As of the latest trading session, CSTL stock price is $20.92, with a market capitalization of $634.6M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Castle Biosciences, Inc. (CSTL) stock price is $20.92. The stock is traded on NASDAQ under the ticker symbol CSTL. The 52-week range is $14.59 – $44.28.